Jefferies Financial Group Lowers Trex (NYSE:TREX) Price Target to $73.00
Trex (NYSE:TREX – Free Report) had its price objective decreased by Jefferies Financial Group from $77.00 to $73.00 in a report issued on Wednesday morning, Benzinga reports. Jefferies Financial Group currently has a hold rating on the construction company’s stock. TREX has been the topic of a number of other research reports. Barclays dropped their […]
First Bancorp (NASDAQ:FBNC) Upgraded at StockNews.com
StockNews.com upgraded shares of First Bancorp (NASDAQ:FBNC – Free Report) from a sell rating to a hold rating in a research note published on Wednesday. Separately, Keefe, Bruyette & Woods increased their price objective on First Bancorp from $40.00 to $45.00 and gave the stock an outperform rating in a research note on Thursday, July […]
KeyCorp Boosts Trade Desk (NASDAQ:TTD) Price Target to $130.00
Trade Desk (NASDAQ:TTD – Free Report) had its price target raised by KeyCorp from $115.00 to $130.00 in a research note released on Wednesday, Benzinga reports. They currently have an overweight rating on the technology company’s stock. TTD has been the topic of several other reports. Bank of America began coverage on shares of Trade […]
OnKure Therapeutics (NASDAQ:OKUR) Raised to “Strong-Buy” at Lifesci Capital
Lifesci Capital upgraded shares of OnKure Therapeutics (NASDAQ:OKUR – Free Report) to a strong-buy rating in a research report report published on Thursday, Zacks.com reports. Separately, Oppenheimer assumed coverage on shares of OnKure Therapeutics in a research note on Thursday. They set an outperform rating and a $35.00 target price for the company. Get Our […]
Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of NASDAQ AKTX opened at $2.70 on Wednesday. Akari Therapeutics has a one year low of $1.08 and a one year […]
Tesla (NASDAQ:TSLA) Given Hold Rating at Needham & Company LLC
Needham & Company LLC reaffirmed their hold rating on shares of Tesla (NASDAQ:TSLA – Free Report) in a report published on Friday morning, Benzinga reports. A number of other brokerages have also commented on TSLA. Guggenheim increased their price target on shares of Tesla from $134.00 to $153.00 and gave the stock a sell rating […]
Builders FirstSource (NYSE:BLDR) Price Target Raised to $223.00
Builders FirstSource (NYSE:BLDR – Free Report) had its price objective hoisted by Jefferies Financial Group from $185.00 to $223.00 in a report issued on Wednesday, Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock. Other analysts have also recently issued reports about the stock. Baird R W raised shares of Builders […]
Avis Budget Group (NASDAQ:CAR) Price Target Cut to $90.00 by Analysts at The Goldman Sachs Group
Avis Budget Group (NASDAQ:CAR – Free Report) had its price objective reduced by The Goldman Sachs Group from $105.00 to $90.00 in a research report released on Friday morning, Benzinga reports. They currently have a neutral rating on the business services provider’s stock. A number of other analysts have also recently weighed in on CAR. […]
Jefferies Financial Group Trims Summit Materials (NYSE:SUM) Target Price to $56.00
Summit Materials (NYSE:SUM – Free Report) had its target price lowered by Jefferies Financial Group from $58.00 to $56.00 in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the construction company’s stock. A number of other equities analysts also recently commented on the stock. Stifel Nicolaus reduced […]
Ayala Pharmaceuticals (NASDAQ:ADXS) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance Ayala Pharmaceuticals stock opened at $0.03 on Wednesday. The firm has a market cap of $1.15 million, a price-to-earnings ratio of […]
Bicara Therapeutics (NASDAQ:BCAX) Research Coverage Started at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage on shares of Bicara Therapeutics (NASDAQ:BCAX – Free Report) in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage issued an overweight rating on the stock. Cantor Fitzgerald also issued estimates for Bicara Therapeutics’ FY2024 earnings at ($1.61) EPS. Several other research analysts also recently commented on […]
Chesapeake Energy (NASDAQ:EXE) Price Target Increased to $89.00 by Analysts at UBS Group
Chesapeake Energy (NASDAQ:EXE – Free Report) had its target price boosted by UBS Group from $85.00 to $89.00 in a report released on Tuesday, Benzinga reports. UBS Group currently has a neutral rating on the stock. Separately, Roth Capital raised Chesapeake Energy to a strong-buy rating in a research note on Friday, September 27th. Get […]
Citigroup Cuts Summit Materials (NYSE:SUM) Price Target to $46.00
Summit Materials (NYSE:SUM – Free Report) had its price target reduced by Citigroup from $47.00 to $46.00 in a report published on Wednesday, Benzinga reports. They currently have a buy rating on the construction company’s stock. SUM has been the topic of several other reports. Morgan Stanley assumed coverage on Summit Materials in a report […]
CoStar Group (NASDAQ:CSGP) Upgraded at StockNews.com
StockNews.com upgraded shares of CoStar Group (NASDAQ:CSGP – Free Report) from a sell rating to a hold rating in a report issued on Tuesday. CSGP has been the topic of a number of other reports. Keefe, Bruyette & Woods cut their target price on CoStar Group from $109.00 to $100.00 and set an outperform rating […]
CoStar Group (NASDAQ:CSGP) Upgraded to Hold by StockNews.com
StockNews.com upgraded shares of CoStar Group (NASDAQ:CSGP – Free Report) from a sell rating to a hold rating in a research note published on Tuesday. Other analysts also recently issued research reports about the stock. Royal Bank of Canada reissued an outperform rating and set a $96.00 price target on shares of CoStar Group in […]
Curbline Properties (NYSE:CURB) Coverage Initiated at Citigroup
Citigroup assumed coverage on shares of Curbline Properties (NYSE:CURB – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat reports. The firm issued a neutral rating and a $25.00 target price on the stock. CURB has been the topic of several other research reports. Stifel Nicolaus initiated coverage on shares of […]
F.N.B. (NYSE:FNB) Downgraded by StockNews.com
StockNews.com lowered shares of F.N.B. (NYSE:FNB – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday. FNB has been the topic of several other research reports. Keefe, Bruyette & Woods reiterated a market perform rating and set a $16.00 price target on shares of F.N.B. […]
Helen of Troy (NASDAQ:HELE) Given New $71.00 Price Target at DA Davidson
Helen of Troy (NASDAQ:HELE – Free Report) had its price target increased by DA Davidson from $67.00 to $71.00 in a research report sent to investors on Thursday, Benzinga reports. They currently have a neutral rating on the stock. DA Davidson also issued estimates for Helen of Troy’s Q3 2025 earnings at $2.48 EPS. Other […]
InMode’s (INMD) Hold Rating Reiterated at Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of InMode (NASDAQ:INMD – Free Report) in a research report report published on Thursday morning, Benzinga reports. Several other equities research analysts have also recently issued reports on INMD. Canaccord Genuity Group lowered their price objective on InMode from $21.00 to $16.00 and set a […]
KeyCorp Initiates Coverage on Acadia Healthcare (NASDAQ:ACHC)
Stock analysts at KeyCorp initiated coverage on shares of Acadia Healthcare (NASDAQ:ACHC – Get Free Report) in a research note issued on Friday, Briefing.com reports. The brokerage set a “sector weight” rating on the stock. ACHC has been the subject of several other research reports. Royal Bank of Canada reiterated an “outperform” rating and set […]
Mizuho Trims Par Pacific (NYSE:PARR) Target Price to $26.00
Par Pacific (NYSE:PARR – Free Report) had its target price decreased by Mizuho from $28.00 to $26.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Mizuho currently has an outperform rating on the stock. Other equities analysts have also issued research reports about the company. UBS Group dropped their target price […]
OnKure Therapeutics (NASDAQ:OKUR) Coverage Initiated at Oppenheimer
Investment analysts at Oppenheimer assumed coverage on shares of OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) in a note issued to investors on Thursday, Marketbeat Ratings reports. The firm set an “outperform” rating and a $35.00 price target on the stock. Oppenheimer’s price objective indicates a potential upside of 90.01% from the stock’s previous close. […]
Rivian Automotive (NASDAQ:RIVN) Price Target Cut to $11.00 by Analysts at The Goldman Sachs Group
Rivian Automotive (NASDAQ:RIVN – Free Report) had its price target reduced by The Goldman Sachs Group from $13.00 to $11.00 in a research note published on Tuesday, Benzinga reports. They currently have a neutral rating on the electric vehicle automaker’s stock. Several other equities research analysts have also recently commented on the company. Canaccord Genuity […]
Snap (NYSE:SNAP) Receives Neutral Rating from Cantor Fitzgerald
Cantor Fitzgerald reiterated their neutral rating on shares of Snap (NYSE:SNAP – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $8.00 price objective on the stock. Other research analysts have also issued reports about the company. Truist Financial lowered their price objective on Snap from $16.00 to $13.00 and […]
Southside Bancshares (NASDAQ:SBSI) Rating Lowered to Sell at StockNews.com
StockNews.com downgraded shares of Southside Bancshares (NASDAQ:SBSI – Free Report) from a hold rating to a sell rating in a research report report published on Thursday. Separately, Hovde Group boosted their target price on Southside Bancshares from $31.00 to $37.00 and gave the stock a market perform rating in a research report on Monday, July […]
StockNews.com Downgrades Clean Harbors (NYSE:CLH) to Buy
StockNews.com cut shares of Clean Harbors (NYSE:CLH – Free Report) from a strong-buy rating to a buy rating in a report released on Tuesday. Other equities research analysts also recently issued research reports about the stock. Stifel Nicolaus reaffirmed a buy rating and issued a $275.00 target price (up previously from $240.00) on shares of […]
StockNews.com Downgrades Clean Harbors (NYSE:CLH) to Buy
StockNews.com cut shares of Clean Harbors (NYSE:CLH – Free Report) from a strong-buy rating to a buy rating in a report released on Tuesday. Other equities research analysts also recently issued research reports about the stock. Stifel Nicolaus reaffirmed a buy rating and issued a $275.00 target price (up previously from $240.00) on shares of […]
Valaris (NYSE:VAL) Price Target Lowered to $61.00 at Susquehanna
Valaris (NYSE:VAL – Get Free Report) had its price target dropped by equities researchers at Susquehanna from $62.00 to $61.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Susquehanna’s target price indicates a potential upside of 15.60% from the company’s current price. A number […]
Vanda Pharmaceuticals (NASDAQ:VNDA) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald boosted their target price on Vanda Pharmaceuticals from $11.00 to $13.00 and gave the company an overweight rating in a research note […]
Vital Farms (NASDAQ:VITL) Price Target Raised to $48.00 at DA Davidson
Vital Farms (NASDAQ:VITL – Free Report) had its price objective upped by DA Davidson from $44.00 to $48.00 in a report published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Other research analysts have also recently issued reports about the stock. Stifel Nicolaus reduced their price target on […]
last updated on 13 Oct 12:17